Drug Profile
BM 170865
Latest Information Update: 08 Nov 2006
Price :
$50
*
At a glance
- Originator Roche
- Class
- Mechanism of Action Thrombopoietin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombocytopenia
Most Recent Events
- 08 Nov 2006 Discontinued - Preclinical for Thrombocytopenia in Germany (unspecified route)
- 13 Mar 2001 No-Development-Reported for Thrombocytopenia in Germany (Unknown route)
- 12 Jan 1999 New profile